Table 4.

Treatment effect on percent change to 12 months in geometric mean EPO dose subgroup analyses in daily trial

Subgroup factor	Subgroup	Estimated effect	Lower 95% CI limit	Upper 95% CI limit	Interaction P-value
ESRD	<4 years	−4.64	−32.13	34.00	0.94
Vintage	≥4 years	−30.55	−53.80	4.41
Age	≤50 years	−19.73	−44.38	15.84	0.38
	>50 years	−12.52	−39.45	26.38
Baseline GFR	GFR ≤1 mL/min	−22.93	−43.13	4.45	0.72
	GFR >1 mL/min	12.98	−30.24	82.97
Diabetes	No diabetes	0.46	−27.69	39.57	0.07
	Diabetes	−37.80	−58.29	−7.24